NASDAQ · LFSC
F/m Emerald Life Sciences Innovation
$45.10 -$0.36 (-0.79%) 1D Market openKey Metrics
—
Market cap
—
P/E · TTM
—
Revenue · TTM
—
Net income
EPS · TTM
—
Dividend yield
—
Free cash flow
—
Beta · 1Y
1.17
EBITDA · TTM
—
Gross margin
—
Snapshot
Market cap—
Enterprise value—
Shares outstanding—
52-wk range$24.22 – $47.68
Avg volume · 20D3.9K
Net cash
—
Book value / share—
ExchangeNASDAQ
About F/m Emerald Life Sciences Innovation
IPO dateOct 30, 2024
Employees—
Wolf Grade COMING SOON
—
The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.
Valuation
P/E—
P/S—
P/FCF—
EV/EBITDA—
EV/Sales—
Graham №—
Profitability
Gross
—
Operating
—
Net
—
FCF
—
ROE / ROIC
— · —
Financial Health
Current ratio—
Quick ratio—
Debt / equity—
Debt / EBITDA
—
Net cash
—
Working capital—
Cash Flow · TTM
Operating CF
—
Capex
—
Free cash flow
—
Buybacks
—
Dividends paid
—
Shareholder yield
—
Piotroski F-Score
—
Needs two fiscal years of filings
Altman Z-Score
—
Insufficient balance-sheet inputs
Graham Number vs Price
—
Requires positive earnings and book value